Causes of the urinary concentrating defect in mice with nephrogenic diabetes insipidus.
In a strain of mice called DI +/+ Severe, nephrogenic (or vasopressin-resistant) diabetes insipidus is caused by an inability of the antidiuretic hormone (ADH, or vasopressin) to increase the water permeability of the renal collecting system. That inability, in turn, arises from abnormally high activity of the enzyme cAMP-phosphodiesterase, specifically of the isozyme type III (PDE-III), which hydrolyzes cAMP and prevents the intracellular buildup of this second messenger. Two rather specific inhibitors of PDE-III, rolipram and cilostamide, used either in vitro or in vivo, reverse the deficiencies in DI +/+ Severe mice by increasing intracellular cAMP and water permeability toward or to their normal values. These results have implications for the treatment of nephrogenic diabetes insipidus in human patients.
Valtin
H
H
Department of Physiology, Dartmouth Medical School, Hanover, NH.
Coffey
A K
AK
O'Sullivan
D J
DJ
Homma
S
S
Dousa
T P
TP
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D000818:Animals; D001834:Body Water / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D003919:Diabetes Insipidus / Q000503:physiopathology*; D007671:Kidney Concentrating Ability; D051379:Mice; D010539:Permeability; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology; D020889:Rolipram; D014667:Vasopressins / Q000502:physiology
D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D015363:Quinolones; D014667:Vasopressins; C021294:cilostamide; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D020889:Rolipram